Dr. Sarika Wairkar
Associate Professor
Qualification : M. Pharm. Ph.D.
Specialization : Quality Assurance
E mail : sarika.wairkar@nmims.edu
Phone : 022-42332000
Experience : 18.5 Years
(Industry: Six years and 4 months, Academic: Twelve years and 2 months)
She has six and half years of rich experience of R & D in the field of formulation development and quality assurance. She has worked in ‘Formulation development’ of solid dosage form including immediate release tablets/ capsules, extended release tablets/capsules, controlled release tablets, effervescent tablets for regulatory markets and successfully completed technology transfer of the developed products for commercial production. She has expertise in trouble shooting at production plant, development report preparation and technology transfer for regulatory market. Recently she has published series of good impact factor research and review papers.
Interest areas
- Nanotechnology
- Nasal drug delivery
- Particle Engineering of drugs
Research
- Publications – Total number (International- 62)
- Patents- 3
- Presentations- 19 (International-14, National- 5)
- Government funded projects – 1 (Completed)
Received grant of 20,00,000 for project titled "Novel intranasal delivery of Antiparkinson agents” from Council of Scientific & Industrial Research (CSIR)- Extramural Research Division.) for 2013-2017
- Industry sponsored project titled "Formulation and development of Generic products” (For US market), of 4 Lakhs, by Intelliscend pvt. Ltd for 6 months received in January 2016 (Completed).
- Industry sponsored project titled "Water soluble granules” 1.22 lakh received in January 2021 (Completed).
- Study of Liposome Formulation 21,712/- received in January 2022 (Completed).
- Characterisation of excipient 29,854/- received in April 2022 (Ongoing).
- Seed grant of 80,000/ by NMIMS university received in 2017- (Completed)
- Seed grant of 80,000/ by NMIMS university received in 2021- (Ongoing)
Conferences/Workshops/Seminars attended- 40
Academic activities- She has guided 45 M.Pharm students for their major research projects and 16 M.Pharm students for their minor research projects.
Awards
· Recipient of ICMR travel grant 1.5 lacs for presenting research paper in "The 44th Annual Meeting & Exposition of the Controlled Release Society” at Boston, USA, July, 2017 |
· Recipient of Best faculty (Teaching) for SPPSPTM, NMIMS, Mumbai for year 2017-2018 |
· Secured Second Rank at M.Pharm, in the merit list of Bharati Vidyapeeth Deemed University, Pune |
· Gold medalist, B. Pharm examination, Shivaji University, Kolhapur |
· Recipient of ‘Best outgoing student award’ Bharati Vidyapeeth College of Pharmacy Kolhapur, year 2002 |
· Recipient of prestigious ‘Prof. M. L. Khorana Award and Merit Certificate” for standing first in Shivaji University, Kolhapur (B. Pharm) |
· The Indian Pharmaceutical Association (Maharashtra state branch) recognition certificate and medal for standing first in the B.Pharm Examination of Shivaji University |
Professional Memberships
- Life Member, Association for Pharmaceutical Teachers of India (MA-LM-2085)
- Life Member, Indian Pharmaceutical Association (MAH/BOM/LM-1426)
- Life Member of Society of Pharmaceutical Education and Research, Dehradun.
Recent Publications
- Kunde SS, Wairkar S. Folic acid anchored urchin-like raloxifene nanoparticles for receptor targeting in breast cancer: Synthesis, optimisation and in vitro biological evaluation. International Journal of Pharmaceutics. 2022 Jul 25;623:121926. (Impact factor-6.51, Elsevier)
- Mohan V, Wairkar S. Breakable foam of mupirocin for topical application on burn wounds: Statistical optimization and antimicrobial study. Journal of Drug Delivery Science and Technology. 2022 Jul 1;73:103448. (Impact factor-5.1, Elsevier)
- Wairkar S, Patel D, Singh A. Nanostructured lipid carrier based dermal gel of cyclosporine for atopic dermatitis-in vitro and in vivo evaluation. Journal of Drug Delivery Science and Technology. 2022 Jun 1;72:103365. (Impact factor-5.1, Elsevier)
- Kapalatiya H, Patel D, Singh AD, Wairkar S. Processability and Oral Bioavailability Improvement of Itraconazole by Particle Engineering Technique. AAPS PharmSciTech. 2022 Dec 28;24(1):27. (Impact factor-4.026, Elsevier)
- Gupta D, Prabhakar B, Wairkar S. Non-oral routes, novel formulations and devices of contraceptives: An update. Journal of Controlled Release. 2022 (Impact factor-11.46, Elsevier)
- Gajbhiye S, Wairkar S. Collagen fabricated delivery systems for wound healing: A new roadmap. Biomaterials Advances. 2022 Oct 12:213152. (Impact factor-8.45, Elsevier)
- Patel D, Patel B, Wairkar S. Intranasal delivery of biotechnology-based therapeutics. Drug Discovery Today. 2022 Sep 26:103371. (Impact factor-8.36, Elsevier)
- Mohale S, Kunde SS, Wairkar S. Biomimetic fabrication of nanotherapeutics by leukocyte membrane cloaking for targeted therapy. Colloids and Surfaces B: Biointerfaces. 2022 Aug 24:112803. (Impact factor-5.99, Elsevier)
- Pant N, Wairkar S. Topical nanocrystals of bioflavonoids: A new technology platform for skin ailments. International Journal of Pharmaceutics. 2022 Mar 29:121707. (Impact factor-5.6, Elsevier)
- Raju M, Kunde SS, Auti ST, Kulkarni YA, Wairkar S. Berberine loaded nanostructured lipid carrier for Alzheimer's disease: Design, statistical optimization and enhanced in vivo performance. Life Sciences. 2021;285:119990. (Impact factor-5.037, Elsevier)
- Patel D, Wairkar S. Biotechnology-based therapeutics for management of cerebral stroke. European journal of pharmacology. 2021;913:174638. (Impact factor-4.42, Elsevier)
- Patel D, Vora A, Wairkar S. Design of experiment‐based LC‐MS/MS method development for simultaneous estimation of nateglinide and metformin hydrochloride in rat plasma. Journal of Mass Spectrometry. 2021;56(11):e4789. (Impact factor-1.9, Wiley)
- Vyas D, Patel M, Wairkar S. Strategies for active tumor targeting-an update. European Journal of Pharmacology. 2021 Sep 20:174512. (Impact factor-4.42, Elsevier)
- Kunde SS, Wairkar S. Platelet membrane camouflaged nanoparticles: biomimetic architecture for targeted therapy. International Journal of Pharmaceutics. 2021 Feb 25:120395. (Impact factor-4.8, Elsevier)
- Nautiyal A, Wairkar S. Management of Hyperpigmentation: Current Treatments and Emerging Therapies. Pigment Cell & Melanoma Research. 2021. (Impact factor-4.6, Wiley)
- Nagula RL, Wairkar S. Cellulose microsponges based gel of naringenin for atopic dermatitis: Design, optimization, in vitro and in vivo investigation. International Journal of Biological Macromolecules. 2020 Dec 1;164:717-25. (Impact factor-5.1, Elsevier)
- Gupta S, Wairkar S, Bhatt LK. Isotretinoin and α-tocopherol acetate-loaded solid lipid nanoparticle topical gel for the treatment of acne. Journal of Microencapsulation. 2020 Nov 16;37(8):557-65. (Impact factor-2.2, Elsevier)
- Gujar K, Wairkar S. Nanocrystal technology for improving therapeutic efficacy of flavonoids. Phytomedicine. 2020 May 15:153240. (Impact factor-4.8, Elsevier)
- Jariwala DH, Patel D, Wairkar S. Surface functionalization of nanodiamonds for biomedical applications. Materials Science and Engineering: C. 2020 Apr 22:110996. (Impact factor-5.88, Elsevier)
- Sridhar V, Gaud R, Bajaj A, Wairkar S*. Pharmacokinetics and pharmacodynamics of intranasally administered selegiline nanoparticles with improved brain delivery in Parkinson's disease. Nanomedicine: Nanotechnology, Biology and Medicine. 2018 Nov 1;14(8):2609-18. (Impact factor-6.5, Elsevier)
- Nagula R, Wairkar S*. Recent advances in topical delivery of flavonoids: A review, Journal of Controlled Release. 2019; 296: 190-201. (Impact factor-7.8; Elsevier)
- Ruhi Raj, Wairkar S*, Vinay Sridhar, Ram Gaud; Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activity; International Journal of Biological Macromolecules; Volume 109, 1 April 2018, Pages 27–35. (Impact factor-3.67, Elsevier).
- Tinwala H, Wairkar S*. Production, surface modification and biomedical applications of nanodiamonds: A sparkling tool for theranostics. Materials Science and Engineering: C. 2019, 97: 913-931 (Impact factor-5.08, Elsevier)
- Kedia K, Wairkar S*. Improved micromeritics, packing properties and compressibility of high dose drug, Cycloserine, by spherical crystallization. Powder Technology. 2019 Feb 15;344:665-72. (Impact factor-3.2, Elsevier)
- Gujar K, Wairkar S*. Nanocrystal technology for improving therapeutic efficacy of flavonoids. Phytomedicine. 2020 May 15:153240. (Impact factor 4.18, Elsevier)
- Nitsure A, Patel D, Wairkar S*. Improved processability of ethambutol hydrochloride by spherical agglomeration. Pharmaceutical Development and Technology. 2020 Mar 15;25(3):376-84. (Impact factor 2.2, Taylor and Francis)
- Jain R, Wairkar S*. Recent developments and clinical applications of surgical glues: An overview. International journal of biological macromolecules. 2019 Sep 15;137:95-106. (Impact factor 4.7, Elsevier)
- Sridhar V, S Wairkar*, R Gaud, A Bajaj, P Meshram. Brain targeted delivery of Mucoadhesive Thermosensitive Nasal Gel of Selegiline Hydrochloride for treatment of Parkinson's disease. Journal of Drug Targeting. 2018 Feb 7; 26(2):150-61. (Impact factor-3.08).